Mechanisms of tumor suppression by the SCFFbw7

被引:104
作者
Minella, AC
Clurman, BE
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词
cell cycle; cyclin E; ubiquitination; Fbw7; SCF complex; tumorigenesis; Ras;
D O I
10.4161/cc.4.10.2058
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
SCF ubiquitin ligases regulate the degradation of many proteins involved in the control of cell division and growth. F-box proteins are the SCF components that bind to substrates, and this binding is usually signaled by substrate phosphorylation. The Fbw7/hCdc4 F-box protein was first recognized by its ability to bind cyclin E, and the SCFFbw7 is now known to target c-Myc, c-Jun and Notch for degradation in addition to its role in cyclin E proteolysis. Fbw7 thus negatively regulates several key oncoproteins. Accordingly, Fbw7 is a tumor suppressor that is mutated in a wide spectrum of human cancers, and Fbw7 functions as a haploinsufficient tumor suppressor in mice. Because there are three Fbw7 isoforms that reside in different subcellular compartments, as well as multiple Fbw7 substrates that are the products of proto-oncogenes, the mechanisms of tumor suppression by Fbw7 are complex and incompletely understood. In this review we discuss the activities of the SCFFbw7 in the context of its role as a tumor suppressor and highlight recent findings demonstrating that dominant oncogenes disable Fbw7 function.
引用
收藏
页码:1356 / 1359
页数:4
相关论文
共 62 条
[11]   Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase itch [J].
Gao, M ;
Labuda, T ;
Xia, Y ;
Gallagher, E ;
Fang, D ;
Liu, YC ;
Karin, M .
SCIENCE, 2004, 306 (5694) :271-275
[12]   Cyclin E ablation in the mouse [J].
Geng, Y ;
Yu, QY ;
Sicinska, E ;
Das, M ;
Schneider, JE ;
Bhattacharya, S ;
Rideout, WM ;
Bronson, RT ;
Gardner, H ;
Sicinski, P .
CELL, 2003, 114 (04) :431-443
[13]   Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor [J].
Gupta-Rossi, N ;
Le Bail, O ;
Gonen, H ;
Brou, C ;
Logeat, F ;
Six, E ;
Ciechanover, A ;
Israël, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34371-34378
[14]   The ubiquitin system [J].
Hershko, A ;
Ciechanover, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479
[15]   Cyclin E dysregulation and chromosomal instability in endometrial cancer [J].
Hubalek, MM ;
Widschwendter, A ;
Erdel, M ;
Gschwendtner, A ;
Fiegl, HM ;
Müller, HM ;
Goebel, G ;
Mueller-Holzner, E ;
Marth, C ;
Spruck, CH ;
Reed, SI ;
Widschwendter, M .
ONCOGENE, 2004, 23 (23) :4187-4192
[16]   A FAMILY OF PROTEINS STRUCTURALLY AND FUNCTIONALLY RELATED TO THE E6-AP UBIQUITIN PROTEIN LIGASE [J].
HUIBREGTSE, JM ;
SCHEFFNER, M ;
BEAUDENON, S ;
HOWLEY, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2563-2567
[17]   Cyclin E in normal and neoplastic cell cycles [J].
Hwang, HC ;
Clurman, BE .
ONCOGENE, 2005, 24 (17) :2776-2786
[18]   Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice:: evidence for cooperation between cyclin E and Ras but not Myc [J].
Karsunky, H ;
Geisen, C ;
Schmidt, T ;
Haas, K ;
Zevnik, B ;
Gau, E ;
Möröy, T .
ONCOGENE, 1999, 18 (54) :7816-7824
[19]   Skp2 regulates Myc protein stability and activity [J].
Kim, SY ;
Herbst, A ;
Tworkowski, KA ;
Salghetti, SE ;
Tansey, WP .
MOLECULAR CELL, 2003, 11 (05) :1177-1188
[20]   hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53 [J].
Kimura, T ;
Gotoh, M ;
Nakamura, Y ;
Arakawa, H .
CANCER SCIENCE, 2003, 94 (05) :431-436